Follow MVCC on:
 Follow MVCC on Facebook

Our Participating Clinics and Hospitals

Clinical Trials

Trials New This Month

View Clinical Trials
Randomized Phase II/III Study of Nivolumab plus Ipilimumab plus Sargramostim versus Nivolumab plus Ipilimumab in Patients with Unresectable Stage III or Stage IV Melanoma
A double-blind, randomised, placebo controlled Phase III study of nintedanib plus best supportive care (BSC) versus placebo plus BSC in patients with colorectal cancer refractory to standard therapies
A Randomized Phase III trial of Dabrafenib + Trametinib followed by Ipilimumab + Nivolumab at Progression vs. Ipilimumab + Nivolumab followed by Dabrafenib + Trametinib at Progression in Patients With Advanced BRAFV600 Mutant Melanoma
View Clinical Trials
Missouri Valley Cancer Consortium
6818 Grover Street * Executive Plaza, Suite 301* Omaha, NE 68106
(402) 991-8070